What is the current thinking on Tamoxifen use for high nuclear grade,multifocal,comedonecrosis DCIS ( 4.0cm with tiny margins <mm) treated with MRM with nodes negative? Is there any benefit to its use to irradicate possible microinvasion or to prevent cancer from developing in the other breast? Thanks, Eamona
Dear eamona: Much of the research done on tamoxifen in DCIS has been done on women who have had lumpectomys + radiation. The addition of tamoxifen reduced the incidence of non-invasive and invasive recurrences, second cancers in the opposite breast, and metastasis. Given the reduction of second cancers in the opposite breast and metastasis, it would seem valid to consider the addition of tamoxifen after mastectomy for DCIS.
Copyright 1994-2017MedHelp International.All rights reserved. MedHelp is a division of Aptus Health.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.